GlassScriptPhysician profile
Regina L Brown
NPI 1164018370
$1,782.36
in general payments reported to CMS, 2019-2025
19 companies · $14.20 in 2025
The $14.20 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $427 · 2023: $1,341 · 2025: $14.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $640.78 | 2022-2023 | |
| Lilly USA, LLC | $175.33 | 2022-2023 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $142.03 | 2022-2023 | Farxiga, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $131.06 | 2022-2023 | |
| Novo Nordisk INC | $96.23 | 2023 | Rybelsus, Ozempic |
| Corcept Therapeutics | $80.43 | 2022 | |
| Abbvie INC. | $78.42 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.25 | 2022-2023 | Jardiance |
| Cardiovascular Systems INC. | $75.87 | 2022 | |
| Almatica Pharma LLC | $58.35 | 2022-2023 | Loreev Xr, Sertraline Hcl, Gralise |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.85 | 2022-2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $41.49 | 2022-2023 | Steglatro, Belsomra |
| Axsome Therapeutics, INC. | $28.52 | 2023 | Auvelity |
| Dexcom, INC. | $24.77 | 2023 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $19.56 | 2023 | Tlando, Xyosted, Nocdurna |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impel Pharmaceuticals INC. | $18.02 | 2023 | Trudhesa |
| Exact Sciences Corporation | $17.90 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $14.20 | 2025 | Venaseal |
| Otsuka America Pharmaceutical, INC. | $13.30 | 2023 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.